ArticleJournal of clinical medicine2026

The Pretreatment Glucose-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Ovarian Cancer.

Ece Baydar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.